You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for Patent: 6,953,569


✉ Email this page to a colleague

« Back to Dashboard


Title: Mixed gas microbubble compositions
Abstract:A microbubble preparation formed of a plurality of microbubbles comprising a first gas and a second gas surrounded by a membrane such as a surfactant, wherein the first gas and the second gas are present in a molar ratio of from about 1:100 to about 1000:1, and wherein the first gas has a vapor pressure of at least about (760-x) mm Hg at 37 C., where x is the vapor pressure of the second gas at 37 C., and wherein the vapor pressure of each of the first and second gases is greater than about 75 mm Hg at 37 C.; also disclosed are methods for preparing microbubble compositions, including compositions that rapidly shrink from a first average diameter to a second average diameter less than about 75% of the first average diameter and are stabilized at the second average diameter; kits for preparing microbubbles; and methods for using such microbubbles as ultrasound contrast agents.
Inventor(s): Schutt; Ernest G. (San Diego, CA), Evitts; David P. (La Jolla, CA), Kinner; Rene Alta (San Diego, CA), Anderson; Charles David (Lebanon, NJ), Weers; Jeffry G. (San Diego, CA)
Assignee: Imcor Pharmaceutical Company (San Diego, CA)
Filing Date:Dec 19, 2001
Application Number:10/029,712
Claims:1. An injectable ultrasound contrast agent comprising: (a) a suspension of gas filled microbubbles or microballoons in a physiologically acceptable aqueous carrier comprising surfactants, and additives wherein: (b) the gas is a gas mixture of at least two biocompatible gases A and B; (c) gas B is present in an amount of between 50%-99% by volume; (d) gas B has a water solubility of not more than about 0.5 mM at 25.degree. C. and one atmosphere and an average molecular weight at least about 4 times that of gas A; and, (e) the balance of the mixture is gas A.

2. The injectable contrast agent of claim 1 wherein the aqueous carrier is water.

3. The injectable contrast agent of claim 1 wherein gas B is perfluoropropane.

4. The injectable contrast agent of claim 1 wherein gas B is selected from the group consisting of perfluoropropanes, perfluorobutanes, perfluorocyclobutanes, perfluoropentanes, perfluorocyclopentanes, perfluoro methylcyclobutanes, perfluorohexanes, perfluorocyclohexanes, perfluoro methyl cyclopentanes, perfluoro dimethyl cyclopentanes, perfluoro heptanes, perfluoro cycloheptanes, perfluoro cycloheptanes, perfluoromethyl cyclohexanes, perfluoro dimethyl cyclopentanes, perfluoro trimethyl cyclobutanes perfluoro triethylamines.

5. The injectable contrast agent of claim 1 wherein gas B is selected from group consisting of perfluoropropanes, perfluorobutanes, perfluoropentanes, perfluorohexanes and perfluoro heptanes.

6. The injectable contrast agent of claim 1 wherein gas A is selected from oxygen, nitrogen and carbon dioxide.

7. The injectable contrast agent of claim 1 wherein gas A is air.

8. The injectable contrast agent of claim 1 wherein at least one surfactant is a phospholipid.

9. The injectable contrast agent of claim 1 wherein at least one surfactant comprises a mixture of phospholipids.

10. An injectable ultrasound contrast agent comprising: (a) a suspension of gas filled microbubbles or microballoons in a physiologically acceptable aqueous carrier comprising a surfactant comprised of at least one phospholipid wherein: (b) the gas is a gas mixture of at least two biocompatible gases A and B; (c) gas B is present in an amount of between 0.5-50% by volume; (d) gas B has a water solubility of not more than about 0.5 mM at 25.degree. C. and one atmosphere and an average molecular weight at least about 4 times that of gas A; and, (e) the balance of the mixture is gas A.

11. The injectable contrast agent of claim 10 wherein the physiological aqueous carrier is water.

12. The injectable contrast agent of claim 10 wherein gas B is perfluoropropane.

13. The injectable contrast agent of claim 10 wherein gas B is selected from the group consisting of perfluoropropanes, perfluorobutanes, perfluorocyclobutanes, perfluoropentanes, perfluorocyclopentanes, perfluoro methylcyclobutanes, perfluorohexanes, perfluorocyclohexanes, perfluoro methyl cyclopentanes, perfluoro dimethyl cyclopentanes, perfluoro heptanes, perfluoro cycloheptanes, perfluoro perfluoro trimethyl cycloheptanes, perfluoromethyl cyclohexanes, perfluoro dimethyl cyclopentanes, cyclobutanes perfluoro triethylamines.

14. The injectable contrast agent of claim 10 wherein gas B is selected from group consisting of perfluoropropanes, perfluorobutanes, perfluoropentanes, perfluorohexanes and perfluoroheptanes.

15. The injectable contrast agent of claim 10 wherein gas A is selected from oxygen, nitrogen and carbon dioxide.

16. The injectable contrast agent of claim 10 wherein gas A is air.

17. The injectable contrast agent of claim 10 wherein said surfactant comprises a mixture of phospholipids.

18. The injectable contrast agent of claim 10 wherein gas A and gas B are present in a molar ratio of between about 50:1 to about 1:1.

19. The injectable contrast agent of claim 1 wherein gas A and gas B are present in a molar ratio of between about 1:1 to about 1:50.

20. The injectable contrast agent of claim 10 further comprising additives and stabilizers.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.